Imaging test for cancer spread in the abdomen
Part of Cancer, Digestive system clinical trials.
This trial tests a special imaging injection to see if it can better detect cancer that has spread to the lining of the abdomen in people with stomach or bowel cancer. If you are scheduled for surgery to remove or explore the cancer, this scan might help your doctor plan the best treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with stomach or bowel cancer that started in the digestive tract
- You are planned to have surgery to remove or examine the cancer
- Your doctor expects you to live at least 12 more weeks
- You agree to use birth control during the study if you could become pregnant or get someone pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan (a type of imaging) to look at tumors in people with pancreatic, lung, or bowel cancer. The scan uses a new tracer that may help doctors see cancer more clearly.
This study tests a new imaging agent that may help doctors see solid tumor cancers more clearly on a special scan. If you have or may have a solid tumor, this scan could provide more information about your condition.
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
This trial tests a new PET/CT scan using a special tracer to detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in people with colorectal, stomach, ovarian, or pancreatic cancer. It aims to see if this scan is better at finding the spread than standard imaging.
This study tests a new imaging agent that may help doctors see tumors more clearly using a special scan (SPECT). It is for people with solid tumors to check if the agent is safe and how well it finds cancer cells.
This study tests a new imaging technique using a special tracer (68Ga-DOTA-BLP) that may help spot cancer more accurately. It is for people with confirmed cancer who have suspicious lymph nodes or possible spread, and who have not yet started cancer treatment.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.